- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/593 - 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
Patent holdings for IPC class A61K 31/593
Total number of patents in this class: 1339
10-year publication summary
|
109
|
124
|
124
|
119
|
136
|
170
|
145
|
120
|
98
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| EirGen Pharma Limited | 88 |
41 |
| Wisconsin Alumni Research Foundation | 3923 |
40 |
| DSM IP Assets B.V. | 5472 |
40 |
| Société des Produits Nestlé S.A. | 9928 |
38 |
| LEO Pharma A/S | 461 |
17 |
| N.V. Nutricia | 1080 |
16 |
| Journey Medical Corporation | 95 |
14 |
| AMBO Innovations, LLC | 30 |
12 |
| Opko Ireland Global Holdings, Ltd. | 18 |
11 |
| Ldn Pharma Limited | 44 |
11 |
| Nulixir Inc. | 41 |
11 |
| The Board of Trustees of the Leland Stanford Junior University | 6590 |
10 |
| Nestec S.A. | 2616 |
9 |
| The Trustees of the University of Pennsylvania | 4382 |
8 |
| Albert Einstein College of Medicine, Inc. | 588 |
8 |
| Matthias W. Rath | 24 |
8 |
| URGO Recherche Innovation et Developpement | 303 |
8 |
| Fermenta Biotech Limited | 49 |
7 |
| Lo.li. Pharma S.r.l. | 77 |
6 |
| natals, Inc. | 37 |
6 |
| Other owners | 1018 |